Vandoolaeghe E - Search Results

1

Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression.

Vandoolaeghe E, Maes M, Vandevyvere J, Neels H. Vandoolaeghe E, et al. J Affect Disord. 1997 Apr;43(2):143-50. doi: 10.1016/s0165-0327(96)01426-7. J Affect Disord. 1997. PMID: 9165383

2

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.

Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R. Maes M, et al. Among authors: vandoolaeghe e. J Affect Disord. 1995 Aug 18;34(4):301-9. doi: 10.1016/0165-0327(95)00028-l. J Affect Disord. 1995. PMID: 8550956

3

Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process.

Maes M, Van de Vyvere J, Vandoolaeghe E, Bril T, Demedts P, Wauters A, Neels H. Maes M, et al. Among authors: vandoolaeghe e. J Affect Disord. 1996 Sep 9;40(1-2):23-33. doi: 10.1016/0165-0327(96)00038-9. J Affect Disord. 1996. PMID: 8882911 Clinical Trial.

4

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R. Maes M, et al. Among authors: vandoolaeghe e. J Affect Disord. 1995 Dec 24;36(1-2):29-36. doi: 10.1016/0165-0327(95)00049-6. J Affect Disord. 1995. PMID: 8988262

5

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

Maes M, Vandoolaeghe E, Desnyder R. Maes M, et al. Among authors: vandoolaeghe e. J Affect Disord. 1996 Dec 16;41(3):201-10. doi: 10.1016/s0165-0327(96)00089-4. J Affect Disord. 1996. PMID: 8988452 Clinical Trial.

6

Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.

Van Hunsel F, Wauters A, Vandoolaeghe E, Neels H, Demedts P, Maes M. Van Hunsel F, et al. Among authors: vandoolaeghe e. Psychiatry Res. 1996 Dec 20;65(3):159-69. doi: 10.1016/s0165-1781(96)03010-7. Psychiatry Res. 1996. PMID: 9029664 Clinical Trial.

7

Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers.

Maes M, De Meester I, Verkerk R, De Medts P, Wauters A, Vanhoof G, Vandoolaeghe E, Neels H, Scharpé S. Maes M, et al. Among authors: vandoolaeghe e. Psychoneuroendocrinology. 1997 Feb;22(2):65-78. doi: 10.1016/s0306-4530(96)00040-6. Psychoneuroendocrinology. 1997. PMID: 9149329

8

Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.

Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R. Maes M, et al. Among authors: vandoolaeghe e. Biol Psychiatry. 1997 Sep 1;42(5):349-58. doi: 10.1016/S0006-3223(96)00365-4. Biol Psychiatry. 1997. PMID: 9276075 Clinical Trial.

9

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Maes M, et al. Among authors: vandoolaeghe e. Cytokine. 1997 Nov;9(11):853-8. doi: 10.1006/cyto.1997.0238. Cytokine. 1997. PMID: 9367546

10

Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude.

Vandoolaeghe E, van Hunsel F, Nuyten D, Maes M. Vandoolaeghe E, et al. J Affect Disord. 1998 Mar;48(2-3):105-13. doi: 10.1016/s0165-0327(97)00165-1. J Affect Disord. 1998. PMID: 9543199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters